Around 25% of human cutaneous squamous cell carcinoma contains missense mutations in TrkC, and these missense mutations were also detected in ~7.8% of human lung adenocarcinomas and ~7% uterine endometrial carcinoma patients (Figure 1B). The gene discussed is NTRK3; the disease is lung adenocarcinoma.